Ticker LaunchReverse merger · Pending
Remix Therapeutics, Inc.
Reverse merger with Passage Bio, Inc. (PASG)
Remix Therapeutics, Inc. agreed to merge into Passage Bio, Inc. (PASG), in a reverse merger that takes the private company public. The deal was announced on Jun 24, 2026.
- Status
- Pending
- Private company
- Remix Therapeutics, Inc.
- Public company
- Passage Bio, Inc. (PASG)
- Announced
- Jun 24, 2026
- Exchange
- Nasdaq
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- 8-K amended and restated merger agreement Sep 3, 2026
- S-4/A (registration/proxy) Oct 8, 2026
- All filings on EDGAR CIK 1787297
Other pending reverse mergers
- Caldera Therapeutics, Inc.into Synlogic, Inc. · Jul 29, 2026
- GH Power Inc.into Matinas BioPharma Holdings, Inc. · Jul 13, 2026
- Noble Africa LLC (ASP Isotopes subsidiary holding Renergen)into ENDRA Life Sciences Inc. · Jun 25, 2026
- Fortitude Mining Holdings, Inc. (Fortitude Mining HoldCo, LLC)into HeartSciences Inc. · Jun 23, 2026
- Serapha Bio, Inc.into Boundless Bio, Inc. · Jun 22, 2026
- Avenzo Therapeutics, Inc.into Rallybio Corporation · Jun 1, 2026